Piercing the Veil of Corporate Secrecy About Clinical Trials

The Hastings Center Report, Vol. 34, No. 5, pp. 14-18, 2004

5 Pages Posted: 11 Jun 2008

See all articles by Trudo Lemmens

Trudo Lemmens

University of Toronto - Faculty of Law

Abstract

In the last decades, the pharmaceutical and biotechnology industry has burgeoned into one of the most profitable industries. With profit has come power. Backed by unprecedented financial means and pressured by stockholders' demand for investment returns, pharmaceutical companies have taken a much larger stake in all stages of medical research. Governmental policies and legislative initiatives such as the Bayh-Dole Act have also contributed to a shift in institutional approaches within academia to commercialization. In this paper, the author discusses the impact of these developments on the integrity of medical research.

Suggested Citation

Lemmens, Trudo, Piercing the Veil of Corporate Secrecy About Clinical Trials. The Hastings Center Report, Vol. 34, No. 5, pp. 14-18, 2004, Available at SSRN: https://ssrn.com/abstract=1142875

Trudo Lemmens (Contact Author)

University of Toronto - Faculty of Law ( email )

78 and 84 Queen's Park
Toronto, Ontario M5S 2C5
Canada

Do you have a job opening that you would like to promote on SSRN?

Paper statistics

Downloads
95
Abstract Views
869
rank
325,964
PlumX Metrics